NCT06142656View on ClinicalTrials.gov

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 25, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Poly Cystic Ovary Syndrome
Interventions
DRUG

Metformin Hydrochloride tablet

Metformin Hydrochloride 850 mg oral tablet

DRUG

Vildagliptin 50 MG

Vildagliptin 50 MG oral tablets

Trial Locations (1)

12585

RECRUITING

October 6 university hospital, Giza

All Listed Sponsors
lead

October 6 University

OTHER